Modulos, the leading AI governance platform, has finalized its CHF 8.7 million pre-Series A funding round. The investment positions the company to capitalize on the rapidly expanding AI governance ...

The funding allows MobyFly to expand its activities, develop its engineering and R&D capabilities, accelerate the market launch of its zero-emission hydrofoil technology solutions in a high-demand ...

The Swiss Federal Tax Administration has updated its tax practice related to convertible loans providing startups and investors more flexibility to offer larger conversion discounts without incurring ...

The Innosuisse Certificate recognises startups that have completed Innosuisse Start-up Core Coaching, signifying a company’s growth and success in their market. The following recipients are developing ...

Relief Therapeutics Holding SA has signed a binding term sheet for a proposed business combination with MindMaze’s successor NeuroX Group SA. The envisaged combination aims to create a publicly listed ...

Upon successfully completing the Innosuisse Start-up Core Coaching program, startups can apply for the Innosuisse Certificate. Applicants undergo a thorough evaluation assessing factors such as ...

Boldbrain Startup Challenge, a Ticino-based accelerator for innovative entrepreneurial ideas, has selected twenty teams to participate in the eighth edition. The three-month acceleration program will ...

Terasol SA, the startup dedicated to soil protection and regeneration, has completed its first round of financing, securing one million Swiss Francs. The funding will support the further development ...

Six university projects have each been awarded CHF 150,000 as part of the InnoBooster program by the Gebert Rüf Stiftung. The teams are working on a range of solutions to enable early cancer detection ...

Three student projects have each obtained CHF 50'000 as part of the First ventures program to validate their solutions. They are working on a new matchmaking platform for apprenticeships, software to ...

The Lugano-based biotech startup launches InVirtuo Platform, a modular AI-driven solution already applied to a proprietary metabolic disease project. With the first application targeting metabolic ...

Pharvaris has raised about $201.2 million through an upsized public offering of its shares, including the sale of over 9.5 million ordinary shares and pre-funded warrants for half a million shares.